Pieris Pharma (PIRS) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Pieris Pharma (PIRS) Tops Q3 EPS by 1c

Pieris Pharmaceuticals Reports Financial Results for the Third Quarter Ended September 30, 2015

November 11, 2015 5:45 PM EST

BOSTON, MA -- (Marketwired) -- 11/11/15 -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing its proprietary Anticalin® biotherapeutic technologies, today reported financial results for the third quarter of 2015, and provided an update on the Company's recent developments.

"In this last quarter, Pieris made great strides in advancing its pipeline of Anticalin-based drug candidates, while recruiting top talent to ensure continued progression of these assets in an... More